| Literature DB >> 27559474 |
Nihad Abdallah1, Rory Conn1, Abdel Latif Marini1.
Abstract
Physical health monitoring is an integral part of caring for patients with mental health problems. It is proven that serious physical health problems are more common among patients with severe mental health illness (SMI), this monitoring can be challenging and there is a need for improvement. The project aimed at improving the physical health monitoring among patients with SMI who are receiving antipsychotic medications. The improvement process focused on ensuring there is a good communication with general practitioners (GPs) as well as patient's education and education of care home staff. GP letters requesting physical health monitoring were updated; care home staff and patients were given more information about the value of regular physical health monitoring. There was an improvement in patients' engagement with the monitoring and the monitoring done by GPs was more adherent to local and national guidelines and was communicated with the mental health service.Entities:
Year: 2016 PMID: 27559474 PMCID: PMC4994095 DOI: 10.1136/bmjquality.u210300.w4189
Source DB: PubMed Journal: BMJ Qual Improv Rep ISSN: 2050-1315
The percentage of documented monitoring over the 10 weeks period
| Variables | Baseline measurement | PDSA Cycle 1 (weeks 1-2) | PDSA Cycle 2 (weeks 3-4) | PDSA Cycle 3 (weeks 5-6) | PDSA Cycle 4 (weeks 7-8) | PDSA Cycle 5 (weeks 9-10) |
|---|---|---|---|---|---|---|
| Weight | 0 | 28.6% | 62.5% | 75% | 80% | 78% |
| Blood Pressure | 10% | 28.6% | 62.5% | 75% | 80% | 78% |
| Pulse | 0 | 0 | 37.5% | 75% | 80% | 78% |
| Full Blood Count | 0 | 28.6% | 62.5% | 75% | 80% | 78% |
| Urea & Electrolytes | 0 | 28.6% | 62.5% | 75% | 80% | 78% |
| Fasting blood glucose | 0 | 28.6% | 62.5% | 75% | 80% | 78% |
| Liver Function tests | 0 | 14% | 37.5% | 75% | 80% | 78% |
| HbA1c | 0 | 14% | 25% | 75% | 60% | 78% |
| Blood lipid level | 0 | 14% | 12.5% | 50% | 40% | 56% |
| Prolactin level | 0 | 0 | 0 | 25% | 40% | 44% |
| 95 | 7 | 8 | 4 | 5 | 9 |
The percentage of patients who had bloods done (including the ones not documented)
| Variables | Baseline measurement | PDSA Cycle 1 (weeks 1-2) | PDSA Cycle 2 (weeks 3-4) | PDSA Cycle 3 (weeks 5-6) | PDSA Cycle 4 (weeks 7-8) | PDSA Cycle 5 (weeks 9-10) |
|---|---|---|---|---|---|---|
| Full Blood Count | 50% | 100% | 100% | 100% | 100% | 100% |
| Urea & Electrolytes | 47% | 100% | 100% | 100% | 100% | 100% |
| Fasting blood glucose | 42% | 100% | 100% | 100% | 100% | 100% |
| Liver Function tests | 34% | 86% | 100% | 100% | 100% | 100% |
| HbA1c | 19% | 57% | 100% | 100% | 80% | 100% |
| Blood lipid level | 25% | 14% | 62.5% | 75% | 60% | 67% |
| Prolactin level | 4% | 0 | 25% | 25% | 40% | 56% |
| Total no. of patients | 95 | 7 | 8 | 4 | 5 | 9 |
Figure 1